FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to 3-(heteroarylamino)-1,2,3,4-tetrahydro-9H-carbazole derivatives of formula 
in which R1 represents hydrogen, (C1-C4)alkyl, (C1-C4)alkoxygroup, haloid, trifluoromethoxygroup or trifluoromethyl, R2 represents hydrogen, (C1-C4)alkyl, (C1-C2)alkoxy(C2-C3)alkyl, (C1-C4)fluoroalkyl or (C3-C6)cycloalkyl(C1-C2)alkyl, and R3 represents a heteroaryl group, which is non-substituted or substituted and to their application as modulators of prostaglandin receptors, in particular, the modulators of prostaglandin D2 receptors in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions, containing the claimed compounds and to methods of obtaining thereof.
EFFECT: obtaining pharmaceutical compositions for the treatment of various prostaglandin-mediated diseases and disorders.
23 cl, 10 tbl, 58 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
| MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
| TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
| BICYCLIC LACTAMS AND METHODS OF USE THEREOF | 2016 |
|
RU2827714C1 |
| VIRAL REPLICATION INHIBITORS, METHOD FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | 2014 |
|
RU2678575C2 |
| TRIAZINONE COMPOUND AND T-TYPE CALCIUM CHANNELS INHIBITOR | 2013 |
|
RU2645158C2 |
| QUINAZOLINE DERIVATIVES | 2005 |
|
RU2414468C2 |
| DERIVATIVES OF INDANE ACETIC ACID AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2314298C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
| NOVEL INDOLE AND PYRROLE COMPOUNDS, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2014 |
|
RU2693404C2 |
